Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNABW) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for Ginkgo Bioworks Holdings (DNABW) over the last 6 years, with Q3 2025 value amounting to $8.2 million.

  • Ginkgo Bioworks Holdings' Cost of Revenue fell 1812.36% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.1 million, marking a year-over-year increase of 996.81%. This contributed to the annual value of $38.5 million for FY2024, which is 1714.17% down from last year.
  • As of Q3 2025, Ginkgo Bioworks Holdings' Cost of Revenue stood at $8.2 million, which was down 1812.36% from $9.4 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' Cost of Revenue's 5-year high stood at $81.8 million during Q4 2021, with a 5-year trough of -$870000.0 in Q4 2023.
  • Its 5-year average for Cost of Revenue is $21.8 million, with a median of $11.8 million in 2024.
  • In the last 5 years, Ginkgo Bioworks Holdings' Cost of Revenue soared by 104562.14% in 2021 and then tumbled by 10908.9% in 2023.
  • Ginkgo Bioworks Holdings' Cost of Revenue (Quarter) stood at $81.8 million in 2021, then tumbled by 88.29% to $9.6 million in 2022, then tumbled by 109.09% to -$870000.0 in 2023, then soared by 968.16% to $7.6 million in 2024, then increased by 8.26% to $8.2 million in 2025.
  • Its Cost of Revenue was $8.2 million in Q3 2025, compared to $9.4 million in Q2 2025 and $8.0 million in Q1 2025.